Integral Diagnostics Limited (ASX:IDX)
Australia · Delayed Price · Currency is AUD 2.100
-0.040 (-1.87%)
Jul 17, 2026, 4:10 PM AEST
Integral Diagnostics Market Cap
Integral Diagnostics has a market cap or net worth of 782.23 million as of July 17, 2026. Its market cap has decreased by -20.99% in one year.
Market Cap
782.23M
Enterprise Value
1.35B
Revenue
767.82M
Ranking
n/a
PE Ratio
55.97
Stock Price
2.10
ChartMarket Cap Chart
Since October 21, 2015, Integral Diagnostics's market cap has increased from 263.77M to 782.23M, an increase of 196.56%. That is a compound annual growth rate of 10.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 782.23M | -17.37% |
| Dec 31, 2025 | 946.69M | -12.49% |
| Dec 31, 2024 | 1.08B | 143.25% |
| Dec 29, 2023 | 444.76M | -34.84% |
| Dec 30, 2022 | 682.57M | -31.87% |
| Dec 31, 2021 | 1.00B | 16.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sonic Healthcare | 10.74B |
| Australian Clinical Labs | 437.83M |
| Healius | 290.46M |
| Monash IVF Group | 274.69M |
| Cryosite | 63.45M |
| INOVIQ | 31.67M |
| Rhythm Biosciences | 30.08M |
| BCAL Diagnostics | 28.02M |